Investment
Features
FeesSafety
Academy
More
Pluang+

Hims & Hers faces fraud investigation after FDA and lawsuit issues cause stock to drop 17.8%.

Market News
01 Apr 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

The Schall Law Firm is investigating Hims & Hers Health, Inc. for possible securities law violations after the FDA announced plans to restrict certain pharmaceutical ingredients used by the company in compounded weight loss drugs. Additionally, Hims & Hers is being sued by Novo Nordisk to stop selling these compounded drugs. Following these developments, Hims & Hers shares fell over 17.8% on February 9, 2026. Investors who suffered losses are encouraged to contact the law firm to discuss potential claims.

More News (HIMS)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App